Welcome to LookChem.com Sign In|Join Free

CAS

  • or

107289-17-8

Post Buying Request

107289-17-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Benzenepropanoic acid, a-(1-hydroxyethyl)-, [R-(R*,R*)]- (9CI)

    Cas No: 107289-17-8

  • No Data

  • No Data

  • No Data

  • yuyongmei
  • Contact Supplier

107289-17-8 Usage

Description

(2R,3R)-2-Benzyl-3-hydroxybutyric acid is a chiral chemical compound with the molecular formula C11H14O3. It belongs to the group of hydroxybutyric acids and features a benzyl group attached to the second carbon and a hydroxyl group on the third carbon of the butyric acid chain. This unique structure and properties make it an important building block in organic chemistry, with potential applications in various industries and research areas.

Uses

Used in Organic Synthesis:
(2R,3R)-2-Benzyl-3-hydroxybutyric acid is used as a key intermediate in organic synthesis for the preparation of various derivatives and analogs. Its unique structure allows for further functionalization and modification, making it a valuable compound in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
(2R,3R)-2-Benzyl-3-hydroxybutyric acid is used as a potential pharmaceutical candidate due to its unique structure and properties. It can be employed in the development of new drugs and therapeutic agents, particularly in the areas of central nervous system disorders, metabolic diseases, and other medical conditions.
Used in Biochemistry Research:
(2R,3R)-2-Benzyl-3-hydroxybutyric acid is used as a research tool in biochemistry to study enzyme mechanisms, metabolic pathways, and other biological processes. Its chiral nature and unique structure make it an interesting compound for investigating stereoselective reactions and understanding the role of chirality in biological systems.
Used in Chiral Compounds Synthesis:
(2R,3R)-2-Benzyl-3-hydroxybutyric acid is used as a precursor for the synthesis of chiral compounds, which are essential in various applications, including pharmaceuticals, agrochemicals, and fragrances. Its enantioselective synthesis and resolution can provide access to enantiomerically pure compounds with specific biological activities.

Check Digit Verification of cas no

The CAS Registry Mumber 107289-17-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,2,8 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 107289-17:
(8*1)+(7*0)+(6*7)+(5*2)+(4*8)+(3*9)+(2*1)+(1*7)=128
128 % 10 = 8
So 107289-17-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H14O3/c1-8(12)10(11(13)14)7-9-5-3-2-4-6-9/h2-6,8,10,12H,7H2,1H3,(H,13,14)/t8-,10-/m1/s1

107289-17-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-benzyl-3-hydroxybutanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107289-17-8 SDS

107289-17-8Relevant articles and documents

Inhibition of invasion and capillary-like tube formation by retrohydroxamate-based MMP inhibitors

Choi, Seung-Su,Ji, Ae-Ri,Yu, Seung-Woo,Cho, Bong-Hwan,Park, Jung Dae,Park, Jun Hyoung,Lee, Hyun Soo,Ryu, Seong Eon,Kim, Dong Han,Kang, Jae-Hoon,Lee, Seung-Taek

scheme or table, p. 2032 - 2038 (2012/01/14)

Matrix metalloproteinases (MMPs), a family of zinc-containing endopeptidases, participate in many normal processes such as embryonic development and wound repair, and in many pathological situations such as cancer, atherosclerosis, and arthritis. Peptidomimetic MMP inhibitors were designed and synthesized with Nformylhydroxylamine (retrohydroxamate) as a zinc-binding group and various side chains on the α, P1′, and P2′ positions. Using in vitro MMP assays with purified MMPs (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-14) and fluorogenic peptide substrates, it was found that compounds 2d and 2g selectively inhibit gelatinases (MMP-2 and MMP-9) and interstitial collagenase (MMP-1). They also inhibited the chemo-invasion of fibrosarcoma HT-1080 cells and tube formation of human umbilical vascular endothelial cells in a dosedependent manner. Our results suggest that retrohydroxamate-based MMP inhibitors, especially compounds 2d and 2g, have the potential to be used as therapeutic drugs for cancer and other MMP-related diseases.

128. α-Alkylierung von β-Hydroxycarbonsaeuren ueber 1,3-Dioxan-4-on-Enolate. Highly Diastereoselective α-Alkylation of β-Hydroxycarboxylic Acids Through Lithium Enolates of 1,3-Dioxan-4-ones

Zimmermann, Juerg,Seebach, Dieter,Ha, Tae-Kyu

, p. 1143 - 1155 (2007/10/02)

From serine, β-hydroxyisobutyric acid ("Roche" acid) and β-hydroxybutyric acid, the dioxanones 1-6 were prepared.The generation of the enolates of type 1 with LDA at -75 deg C and alkylation gave products with trans-configuration whereas protonation of the 5-methyl-substituted enolate allowed access to the cis-configurated β-hydroxybutyric-acid derivative 12.Hydrolysis gave the free β-hydroxy acids of "syn"- and "anti"-configuration.Alkylation of the 6-unsubstituted dioxanones 1 and 3 yielded predominantly products resulting from attack in the cis-position of the t-Bu group.The "reactive" conformation of the enolates involved is tentatively derived from the product configuration.The selectivity of the alkylation is also discussed in terms of the results of an ab-initio calculation on the enolates M-P.

THE STEREOSELECTIVE α-ALKYLATION OF CHIRAL β-HYDROXY ESTERS AND SOME APPLICATIONS THEREOF

Frater, G.,Mueller, U.,Guenther, W.

, p. 1269 - 1278 (2007/10/02)

The stereoselectivity of the α-alkylation of chiral β-hydroxy ester is discussed.The configuration of the alkylated product was proved chemically (Scheme 2) .A one pot aldol-alkylation reaction was developed leading stereoselectively to racemic(S*,S*)-α-alkyl-β-hydroxy ester (Scheme 3,4) .Baker's yeast reduction of 2-alkyl-3-keto ester led to valuable chiral (2RS,3S)-intermediates, which were converted via the corresponding dianion to compounds with a chiral quaternary C atom (Scheme 6) .Synthetic applications of the above findings are shown in the synthesis of various chiral compounds (Scheme 8 and 9) .

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 107289-17-8